Diabetes management, between visits.
Glucose monitoring, A1C trajectory, GLP-1 / insulin / oral-agent adherence, and pharmacist-led intervention — all in the rhythm patients can actually keep.
A1C is a 90-day average. Pharmacy is a 7-day touchpoint.
Patients see their endocrinologist quarterly at best. They see their pharmacist almost monthly. We turn that cadence into structured monitoring — glucose patterns, GLP-1 titration, insulin dose response — with pharmacist outreach calibrated to risk.
Best for the long tail of diabetes patients between specialist visits.
Patients on metformin/SGLT2/DPP-4 needing adherence support.
Higher-risk cohort; titration questions arrive weekly.
Side-effect management and adherence in the first 6 months.
Medsense reviews your panel to identify patients who could benefit from this program and matches them on conditions and medications — before any outreach begins.
The Medsense app turns daily glucose data into something patients can actually act on.
Built alongside our pharmacist team and tested with real diabetes patients — the app is the daily-rhythm layer between pharmacy check-ins.
Bluetooth-paired glucometers and CGMs sync automatically. Patients see their last 7, 30, and 90 days in a single trend view.
Plain-language summaries flag dawn-phenomenon spikes, post-meal excursions, and overnight lows so patients know what to ask about.
Dose reminders, injection-day tracking for once-weekly GLP-1s, and side-effect logging that routes to the pharmacist on call.
Secure messaging with the Medsense care team. Most messages answered same business day; titration questions escalate to the prescriber.
A patient-set range, a streak counter, and a short weekly recap that explains what changed — not just a number.
Patients (or the pharmacy) can send a structured summary to their PCP or endocrinologist before the next visit — no PDF wrangling.